Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of diacerein on ocular surface disease in degenerative arthritis patients
TCTR20190930001Completed
- Sponsor
- Research Affairs, Faculty of Medicine, Chulalongkorn University
- Start
- Oct 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of diacerein in ocular surface disease (OSD) and osteoarthritis (OA), sponsored by Research Affairs, Faculty of Medicine, Chulalongkorn University. Started Oct 2019; status: completed.
02
Drugs
diacerein
03
Conditions
ocular surface disease (OSD)osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20190930001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190930001.